Anestesia venosa total em regime de infusão alvo-controlada: uma análise evolutiva
Total intravenous anesthesia as a target-controlled infusion: an evolutive analysis
Fernando Squeff Nora
Resumo
Palavras-chave
Abstract
Keywords
References
Vandam LD. History of Anesthetic Practice. Anesthesia. :1-11.
Wood A. A new method of treating neuralgia by the direct application of opiates to the painful points. Edinburgh Med Surg J. 1855;82:265-281.
Vandam LD. History of Anesthetic Practice. Anesthesia. 2000:1-11.
Jan Van Hemelrijck. Kissin I: History of Intravenous Anesthesia. Textbook of Intravenous Anesthesia. 1997:1-9.
White PF. Propofol: pharmacokinetics and pharmacodynamics. Semin Anesth. 1988;7:4-20.
Sebel PS, Lowdon JD. Propofol: a new intravenous anesthetic. Anesthesiology. 1989;71:260-277.
Smith I, White PF, Nathanson M. Propofol: an update on its clinical uses. Anesthesiology. 1994;81:1005-1043.
Brodie BB, Mark L, Papper EM. The fate oh thiopental in man and a method for its estimation in biological material. J Pharmacol Exp Ther. 1950;98:85-96.
Price HL, Kovnat PJ, Safer JN. The uptake of thiopental by body tissues and its relations to duration of narcosis. Clin Pharmacol Ther. 1960;1:16-22.
Bischoff KB, Dedrick RL. Thiopental pharmacokinetics. J Pharmacol Sci. 1968;57:1346-1351.
Yamaoka K, Nakagawa T, Uno T. Statistical moments in pharmacokinetics. J Pharmacokinet Biopharm. 1978;6:547-558.
Hull CJ, vanBeem HBH, McLeon K. A pharmacodynamic model for pancuronium. Br J Anaesth. 1978;50:1113-1123.
Boyes RN, Scott DB, Jebson PJ. Pharmacokinetics of lidocaine in man. Clin Pharmacol Ther. 1971;12:105-115.
Wagner JG. A safe method for rapidly achieving plasma concentration plateaus. Clin Pharmacol Ther. 1974;16:691-700.
Wagner JG. Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data. J Pharmakinet Biopharm. 1976;4:443-467.
Kruger-Thiemer E. Continuous intravenous infusion and multicompartiment accumulation. Eur J Pharmacol. 1968;4:317-334.
Vaughan DP, Tucker GT. General theory for rapid establishing steady-state drug concentrations using two consecutive constant rate intravenous infusion. Eur J Clin Pharmacol. 1975;9:235-238.
Rigg JRA, Wong TY. A method for achieving rapidly steady-state blood concentrations for i.v. drugs. Br J Anaesth. 1981;53:1247-1257.
Schwilden H, Stoeckel H, Schuttler J. Pharmacological models and their use in clinical anaesthesia. Eur J Anesthesiol. 1986;3:175-208.
Ausems ME, Hug CC Jr. Plasma concentrations of alfentanil required to supplement nitrous oxide anaesthesia for lower abdominal surgery. Br J Anaesth. 1983;55:191s-197s.
Ausems ME, Hug CC Jr, Stanski DR. Plasma concentrations of alfentanil required supplementing nitrous oxide anesthesia for general surgery. Anesthesiology. 1986;65:362-73.
White PF, Dworsky WA, Horai Y. Comparison of continuous infusion fentanil or ketamine versus thiopental: determining the mean effective serum concentrations for outpatient surgery. Anesthesiology. 1983;59:564-569.
White PF. Continuous infusion of thiopental, methohexital or etomidate as adjuvants to nitrous oxide for outpatient anesthesia. Anesth Analg. 1984;63:282-287.
Doze VA, Westphal LM, White PF. Comparison of propofol with methohexital for outpatient anesthesia. Anesth Analg. 1986;65:1189-1195.
Shafer A, Doze VA, White PF. Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia. Anesthesiology. 1988;69:348-356.
Sear JR, Shaw I, Wolf A. Infusion of propofol to supplement nitrous oxide for maintenance of anesthesia. Anaesthesia. 1988;43:18-22.
Schwilden H. A general method for calculation the dosage scheme in linear pharmacokinetics. Eur J Clin Pharmacol. 1981;20:379.
Shafer SL, Varvel JR. Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology. 1991;74:53-63.
Hugues MA, Glass PSA, Jacobs JR. Context-sensitive half-time in multicompartimental pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology. 1992;76:334-341.
Ausems ME, Vuyk J, Hug CC Jr. Comparison of computer-assisted infusion versus intermittent bolus administration of alfentanil as a supplement to nitrous oxide for lower abdominal surgery. Anesthesiology. 1988;68:851-61.
Smith C, McEwan AI, Jhaveri R. The interaction of fentanyl on the Cp50 of propofol for loss of consciousness and skin incision. Anesthesiology. 1994;81:820-828.
Coetzee JF, Glen JB, Wuim CA. Pharmacokinetic model selection for target-controlled infusions of propofol. Anesthesiology. 1995;82:1328-1345.
Shafer SL, Gregg K. Algorithms to rapidly achieve and maintain stable drug concentrations at the site of drug effect with a computer controlled infusion pump. J Pharmacokinetic Biopharm. 1992;20:147-169.
Vuyk J, Lim T, Engbers FHM. The pharmacodynamic interaction of propofol and alfentanil during lower abdominal surgery in female patients. Anesthesiology. 1995;83:8-22.
McClain DA, Hug CC Jr. Intravenous fentanyl kinetics. Clin Pharmacol Ther. 1980;28:106-114.
Jacobs JR, Glass PSA, Reves JG. Opioid Administration by Continuous Infusion. Opioids in Anesthesia. 1990:241-253.
Glass PSA, Shafer SL, Jacobs JR. Intravenous Drug Delivery Systems in Anesthesia. Anesthesia. 1994:389-416.
Shafer SL, Schiwinn DA. Basic Principles of Pharmacology Related to Anesthesia. Miller s Anesthesia. 2005:67-104.
Shafer SL, Youngs EJ. Basic of Pharmacokinetics and Pharmacodynamics Principles. Textbook of Intravenous Anesthesia. 1997:10.
Billard V, Joacqmin S. Comment conduire L analgésie peorpératoire. Cah Anesthesiol. 2001;49:103-111.
Vuyk J, Engbers FHM, Burn AG. Pharmacodynamic interaction between propofol and alfentanil given for induction of anesthesia. Anesthesiology. 1996;4:288-99.
Vuyk J, Mertens MJ, Oolofsen E. Proposal anesthesia and rational opioid selection: determination of optimal EC50-EC95 propofol-opioid concentrations that assure adequate anesthesia and a rapid return of consciousness. Anesthesiology. 1997;87:1549-62.
Hoymork SC, Reader J, Grimsmo B. Bispectral index, predicted and measured drug levels of target controlled infusions of remifentanil and propofol during laparoscopic cholecystectomy and emergence. Acta Anaesthesiol Scand. 2000;44:1138-1144.
Drover DR, Lemmens HJ. Population pharmacodynamics and pharmacokinetics of remifentanil as a supplement to nitrous oxide anesthesia for elective abdominal surgery. Anesthesiology. 1998;89:869-877.
Macquaire V, Cantraine F, Schmartz D. Target-controlled infusion of propofol induction with or without plasma concentration constraint in high-risk adult patients undergoing cardiac surgery. Acta Anaesthesiol Scand. 2002;46:1010-1016.
White M, Schenkels MJ, Engbers FH. Effect-site modeling of propofol using auditory evoked potentials. Br J Anaesth. 1999;82:333-339.
Struys MM, D Smet T, Depoorter B. Comparison of plasma compartment versus two methods for effect compartment-controlled infusion for propofol. Anesthesiology. 2000;92:399-406.
Servin F, Cazalaá JB, Levron JC. Propofol, sufentanil, remifentanil in TCI: Bibliographical study of anesthetic agents used in the Base Primea. 2003.
Glass PSA, Shafer SL, Reves JG. Intravenous drug delivery systems. Miller s Anesthesia. 2005:439-480.
Schnider TW, Minto CF, Gambus . The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology. 1998;88:1170-1182.
Cockshott ID. Propofol (Diprivan) pharmacokinetics and metabolism: an overview. Postgrad Med J. 1995;61(^s3):45-50.
Gepts E, Camu F, Cockshott ID. Disposition of propofol administered as constant rate intravenous infusions in humans. Anesth Analg. 1987;66:1256-1263.
Gepts E, Jonckheer K, Maes V. Disposition kinetics of propofol during alfentanil anaesthesia. Anaesthesia. 1988;43:8-13.
Marsh B, White M, Morton N. Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth. 1991;67:41-48.
Kirkpatrick T, Cockshott ID, Douglas EJ. Pharmacokinetics of propofol in elderly patients. Br J Anaesth. 1988;60:146-150.
Tackley RM, Lewis GT, Prys-Roberts C. Computer controlled infusion of propofol. Br J Anesth. 1989;62:46-53.
Dyck JB, Shafer SL. Effects of age on propofol pharmacokinetic. Sem Anesth. 1992;11:2-4.
Smith C, McEwan AI, Jhaveri R. The interaction of fentanil on the Cp50 of propofol for loss of consciousness and skin incision. Anesthesiology. 1994;81:820-828.
Slepchenko G, Simon N, Goubaux B. Performance of target-controlled sufentanil infusion in obese patients. Anesthesiology. 2003;98:65-73.
Pandin PC, Contraine F, Ewalenko P. Predictive accuracy of target-controlled propofol and sufentanil coinfusion in long-lasting surgery. Anesthesiology. 2000;93:653-661.
Bailey JM, Schweieger IM, Hug CC Jr. Evaluation of sufentanil anesthesia obtained by a computer-controlled infusion for cardiac surgery. Anesth Analg. 1993;76:247-252.
Schraag S, Mohl U, Bothner U. Interaction modeling of propofol and sufentanil on loss of consciousness. J Clin Anesth. 1999;11:391-396.
Barvais L, Heitz D, Schmartz D. Pharmacokinetic model driven infusion of sufentanil and midazolam during cardiac surgery: assessment of the prospective predictive accuracy and the quality of anesthesia. J Cardiothorac Vasc Anesth. 2000;14:402-408.
Hudson RJ, Henderson BT, Thomson IR. Pharmacokinetics of sufentanil patients undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2001;15:693-699.
Greely WJ, de Bruijin NP, Davis DP. Sufentanil pharmacokinetics in pediatric cardiovascular patients. Anesth Analg. 1987;66:1067-1072.
Drover DR, Lemmens HJ. Population pharmacodynamics and pharmacokinetics of remifentanil as a supplement to nitrous oxide anesthesia for elective abdominal surgery. Anesthesiology. 1996;84:812-820.
Egan TD, Huizinga B, Guota SK. Remifentanil pharmacokinetics in obese patients versus lean patients. Anesthesiology. 1998;89:562-573.
Dershwitz M, Hoke JF, Rosow CE. Pharmacodynamics and pharmacokinetics of remifentanil in volunteer subjects with severe liver disease. Anesthesiology. 1996;84:812-820.